Sharon A. Lamb Endowed Chair in Nursing
Professor, Physiological Nursing
Director, Center for Symptom Management
2 Koret Way, #N-319Y
San Francisco, CA 94143-0604
Fellow in the American Academy of Nursing, elected in 1986
Recipient of the Oncology Nursing Society/Schering Excellence in Research Award, 1993, 1996
Thirteenth Helen Nahm Research Lecturer, School of Nursing, UCSF, 1993
Recipient of the Best Original Research Paper in Cancer Nursing, 1994, 1996
Awarded Oncology Nursing Society's Distinguished Researcher Award (Career Award), 1997
Awarded Western Institute of Nursing Distinguished Research Lectureship (Career Award), 1999
Oncology Nursing Society/Chiron Excellence of Scholarship and Consistency of Contribution to the Oncology Nursing Literature (Career Award), 2000
Margretta Madden Styles Award for Leadership Excellence from Sigma Theta Tau, Alpha Eta Chapter, 2000
Awarded Sharon A. Lamb Endowed Chair in Nursing, UCSF School of Nursing, 2003
The Episteme Award [details], Sigma Theta Tau International Honor Society of Nursing, 2005
Robert Tiffany Lectureship awarded by the International Society of Nurses in Cancer Care (ISNCC), 2006
(see announcement.pdf[Adobe/Acrobat Reader .pdf document])
Teaching
Dr. Dodd teaches in the Oncology Nursing Specialty, and in 2002 instituted Biomarkers I & II, doctoral courses which
were developed by the Center for Symptom Management Faculty Group.
Research
Dr. Dodd is involved in a program of research testing self-care interventions (PRO-SELF Program) to manage the side effects of cancer treatment (mucositis), and symptoms of cancer (fatigue, pain).
These randomized clinical trials include research team members from the schools of medicine, pharmacy, dentistry, and exercise physiology. Funding Sources: NIH, National Cancer Institute, National Institute of Nursing Research.
Professional Activities
Dr. Dodd serves as a nurse scientist to the National Children's Oncology Group and the
Oncology Nursing Society Multisite Research Taskforce.
She is a reviewer for many professional journals and serves on several editorial boards.
Education Background
RN, Vancouver General Hospital, British Columbia, Canada
BSN, University of Washington, Seattle
MSN, University of Washington, Seattle
PhD, Wayne State University, Detroit
Key Publications
New! Search PubMed for publications by this author.
Dodd, M.J. Managing the Side Effects of Chemotherapy and Radiation Therapy: A Guide for Patients and Their Families (Fourth Edition).
UCSF School of Nursing Press.
A review of this book described it as: "At last, a consumer's pocket guide to identifying and managing the side effects of treatment. Essential reading for informed decision making about treatment alternatives.
Powerfully corroborates research findings into a practical resource guide for patients and families."
Dodd, M.J., Miaskowski, C., Paul, S. (2001).
Symptom clusters and their effect on the functional status of patients with cancer.Oncology Nursing Forum, 28(3), 465-470.
This article reports a new generation of symptom management work. The notion that selected concurrent symptoms that patients experience may have a synergistic adverse effect upon subsequent patient morbidity is truly innovative.
Our research team at UCSF is one of the first to define and report this phenomenon.
Dr. Dodd was invited to present this work at the State-of-the-Science Conference on Symptom Management in Cancer, sponsored by the NIH, National Cancer Institute, and others in July 2002.
Recently, Dr. Dodd and her associates were awarded a research grant from the Oncology Nursing Foundation to continue this important work.
Dodd, M.J., Dibble, S.L., Miaskowski, C., MacPhail, L., Greenspan, D., Paul, S., Shiba, G., & Larson, P.
A randomized clinical trial of the effectiveness of three commonly used mouthwashes to treat chemotherapy-induced mucositis. Journal of Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics, 90, 39-47.
This is the most recent publication reporting on the success in conducting large scale interdisciplinary randomized clinical trials.
The patient problem of treatment-related mucositis remains a critically important area for continued research.
This study provided the basis for a large randomized clinical trial funded by the National Cancer Institute, National Institutes of Health, to test a novel mouthwash (Sargramostim)
in preventing and treating oral mucositis in head and neck cancer patients.
Dodd, M.J., Janson, S., Facione, N. et al.
Advancing the Science of Symptom Management. Journal of Advanced Nursing, 33 (5), 668-676 (2001).
This article reports on the revised model of symptom management.
The original model article was developed and published by the UCSF Center for Symptom Management faculty in 1994.
After further testing and consideration, this same group, under Dr. Dodd's leadership, revised the model and the updated version was published in 2001.
The model continues to be used widely by clinicians and researchers.
Dodd, M.J. The pathogenesis and characterization of oral mucositis associated with cancer therapy. In Innovative approaches to oral mucositis and cancer pain: linking mechanisms to management. Oncology Nursing Forum. Supplement to Volume 31, Number 4, July 2004, 5 - 11.
